Abstract
Through cytotoxicity screening with naphthoquinone derivatives, a novel compound 6-(1-oxoallkyl)-5,8-dimethoxy-1,4-naphthoquinone-S17 (DMNQ-S17) showed its potency against human myeloid leukemia U937 cells. Thus, to elucidate the apoptotic mechanism of DMNQ-S17, this study was performed in myeloid leukemia U937 cells by 2,3-bis [2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide (XTT) assay, eletrophoretic mobility shift assay (EMSA), terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) assay, 4',6-diamidino-2-phenylindole (DAPI) staining, and Western blotting. In the present study, DMNQ-S17 inhibited constitutive NF kappaB activation and its transcriptional activity in U937 cells. In addition, DMNQ-S17 induced apoptotic features such as apoptotic bodies, cell shrinkage and chromatin condensation in U937 cells. Consistently, flow cytometric analysis showed that DMNQ-S17 increased sub-G1 portion and TUNEL positive cells in a concentration-dependent manner. Furthermore, DMNQ-S17 effectively attenuated mitochondrial membrane potential, released cytochrome C, activated caspase-3 expression, and cleaved poly (ADP-ribose) polymerase (PARP). Reversely, caspase-3 and -9 inhibitors also blocked the ...Continue Reading
References
Jul 1, 1986·Annals of Internal Medicine·T D Shenkenberg, D D Von Hoff
Dec 11, 1994·Nucleic Acids Research·M HerrmannJ R Kalden
Feb 7, 1997·Cell·M D JacobsonM C Raff
Mar 31, 2000·Experimental Cell Research·M BamfordR Brown
Mar 31, 2000·Experimental Cell Research·S H Kaufmann, W C Earnshaw
May 19, 2000·Archiv der Pharmazie·G Y SongB Z Ahn
Sep 22, 2001·Cancer Letters·S H KimB Z Ahn
Aug 8, 2002·Current Pharmaceutical Biotechnology·Patrice Decker, Sylviane Muller
Dec 31, 2003·Biochemical and Biophysical Research Communications·Akiko YamakiYoshiko Shimizu
Jan 2, 2004·Cell Biology and Toxicology·E M ParkY M Park
May 17, 2005·Cancer Letters·Soo Jin LeeSung Hoon Kim
May 25, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·David W KohValina L Dawson
Jun 9, 2005·Cell Biology International·Zi-Bing WangYu-Fang Cui
Nov 5, 2005·Leukemia·D CilloniG Saglio
Jan 3, 2006·Annals of the New York Academy of Sciences·Kwang Seok Ahn, Bharat B Aggarwal
Jan 21, 2006·Cancer Research·Xia WangYong Lin
Mar 8, 2006·British Journal of Pharmacology·Jong-Heon WonKyung-Tae Lee
Apr 21, 2006·The Journal of Biological Chemistry·Santosh K SandurBharat B Aggarwal
Jun 23, 2006·Medicinal Chemistry·K KuwanoY Nakanishi
Nov 25, 2006·Hematology·Francesco Lo-Coco, Emanuele Ammatuna
Apr 4, 2007·Annals of the New York Academy of Sciences·Eu-Soo LimSung-Hoon Kim
Jul 17, 2007·Current Drug Discovery Technologies·Udo Döbbeling
Aug 3, 2007·Autophagy·Pengrong YanGutian Xiao
Oct 9, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J L Fernández-Luna
Oct 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Domagoj Vucic, Wayne J Fairbrother
Nov 16, 2007·Current Treatment Options in Oncology·Aaron D Schimmer
Jan 23, 2008·Biochemical Society Transactions·Susan E Logue, Seamus J Martin
Citations
May 30, 2014·The American Journal of Chinese Medicine·Chao-Yun WangChun-Hua Wang
Oct 6, 2010·Leukemia & Lymphoma·Mariano ProvencioCarmen Bellas
May 6, 2016·International Journal of Molecular Sciences·Sun-Hyung HaCheorl-Ho Kim
Jan 14, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Li-Min LiKe Zen
Oct 6, 2009·Archives of Biochemistry and Biophysics·Xiao-Mei ZhuZhi-Yong Sheng